Scientists hunt clues in blood and tissue to crack liver cancer treatment code
NCT ID NCT04145141
Summary
This study aims to understand why some liver cancer patients respond to immunotherapy while others do not. Researchers are collecting blood, tissue, and health data from 132 adults with liver cancer who have received or will receive immunotherapy. By analyzing these samples over time, they hope to find biological markers that can predict treatment success and guide future, more personalized therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.